Latest article
Xeris Prescription drugs Receives European Fee Approval of Ogluo™ (glucagon) Injection for the Therapy...
CHICAGO & DUBLIN - (BUSINESS WIRE) - Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), ein Spezialpharmaunternehmen, das seine...
Why health challenges work | Mirage Information
Why fitness challenges workAll it takes is eight weeks (and a little help)Fitness challenges are one of the biggest trends in the health and...
Diabetes medication, Wegovy, permitted by Meals and Drug Administration for long-term weight administration
Regulators said Friday that a new version of a popular diabetes drug could be sold in the US as a weight loss drugThe...